The prescription drug legislation in the Inflation Reduction Act of 2022 — backed by AARP — directed the Department of Health and Human Services to work with pharmaceutical companies to secure reduced ...

In a groundbreaking move, the Centers for Medicare and Medicaid Services (CMS) announced potential savings of up to $685 million for over 55 million Medicare Part D enrollees. This initiative, part of ...

A new round of Medicare drug price negotiations shows the impact of the Inflation Reduction Act while exposing an ongoing political fight over who deserves credit for lowering drug costs. The Trump ...

Pharmacies will be the canary in the coal mine for the Medicare Drug Price Negotiation Program, writes Sujith Ramachandran.

As Trump takes a victory lap on lower drug prices, he should thank Biden for signing a key law that made it possible.

Pharmaceutical companies have agreed to slash the Medicare prices for 15 prescription drugs after months of negotiations, reductions that are expected to produce billions in savings for taxpayers and ...

The Centers for Medicare & Medicaid Services announced Nov. 25 that Medicare recipients will pay less for 15 prescription ...

The government said Tuesday that Novo Nordisk's (NVO) drugs - Ozempic and Rybelsus for Type 2 diabetes - will cost $274 for a month's supply in 2027 for people covered by Medicare. Wegovy, which is ...

The Trump administration announced Tuesday that there would be major savings coming to the federal government.

In 2026, there are fewer prescription drug plans in Medicare Part D and higher premiums, even when offset by a ...

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...